3:32 PM
 | 
Mar 07, 2019
 |  BC Extra  |  Company News

Spark bidding war drove Roche bid up by $2.1 billion

Roche's proposed $4.8 billion acquisition of Spark was a 64% increase from its initial $2.7 billion offer in what turned out to be a two-way bidding war for the gene therapy company, according to SEC filings published Thursday.

The documents also revealed that the dueling bids emerged after Spark went looking for partners for its hemophilia A gene therapy.

According to the filing, Spark Therapeutics Inc. (NASDAQ:ONCE) decided in May 2018 to seek partners for its...

Read the full 367 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >